TACI/TNFRSF13B/CVID Antibody Blocking Peptide
Novus Biologicals, part of Bio-Techne | Catalog # NB100-56516PEP
Key Product Details
Conjugate
Unconjugated
Applications
Antibody Competition
Product Specifications
Description
Application Notes
This peptide is useful as a blocking peptide for NB100-56516. For further blocking peptide related protocol, click here.
Specificity
This peptide is specific for NB100-56516 only.
Protein / Peptide Type
Antibody Blocking Peptide
Formulation, Preparation and Storage
NB100-56516PEP
| Formulation | Peptide dissolved in dH20. Contains no BSA. |
| Preservative | No Preservative |
| Concentration | 1 mg/ml |
| Shipping | The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage | Store at -80C. Avoid freeze-thaw cycles. |
Background: TACI/TNFRSF13B
Long Name
Transmembrane Activator and CAML Interactor/Tumor Necrosis Factor Receptor Superfamily Member 13B
Alternate Names
CD267, CVID, TNFRSF13B
Gene Symbol
TNFRSF13B
Additional TACI/TNFRSF13B Products
Product Documents for TACI/TNFRSF13B/CVID Antibody Blocking Peptide
Product Specific Notices for TACI/TNFRSF13B/CVID Antibody Blocking Peptide
This product is for research use only and is not approved for use in humans or in clinical diagnosis. This product is guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...